RE:APHA/TLRY Merger: Pros & Cons>
Excellent summary especially the fact that Tilray has a negative book value and less than $50 million in sales.
Aphra would be better off buying Hollister ( $0.25 ) with a market less than $70 million, current sales of $60 million enroute to over $150 million in 2021.
It would get hemp and mushroom subsidiaries as well and no debt.
Thanks for pointing out this glaring black hole called Tilray